Not only are the individual’s personal factors considered in determining which treatment is used for cervical cancer but also factors of the cancer itself. This would include how advanced it is and what specific areas are affected by it. These are key factors and are very important and necessary when making the final decision on the specific treatment method that will be of most benefit for the patient. Other information that will also be reviewed includes how many different treatment options will need to be used. As you can see, there are several options to consider in relation to cervical cancer treatment.

Cervical cancer is a type of cancer that is generally treated by using three different types of treatment methods. The most important would involve making sure patients receive HPV treatment before cervical cancer has a chance to occur. Other treatment methods that are commonly used would include the use of radiation therapy and chemotherapy. In several cases, just one form of treatment does not improve the cancer enough on its own. When this problem occurs, then your physician will generally suggest that it be used in conjunction with another form of treatment as well.

Before patients begin cervical cancer treatment, many physicians go out of their way to make sure that the patient is well informed about the treatment options that will be used, and that they feel at ease and comfortable before the procedures begin. Doctors will generally provide their patients with a description on how the procedure will be done, how long the procedure may take, common side effects and risk factors that surround each type of procedure, as well as the advantages and benefits that are involved with each treatment option. During this time it is extremely important to speak with your physician about any type of questions that you may have, or any type of concerns that may have come to mind. This helps to give patients confidence in not only their doctor, but also in the procedures they will undergo.

Two of the most common factors that increase the risk of cervical cancer are medical history and lifestyle particularly sexual proclivities. Human papillomavirus or HPV is a sexually transmitted virus that is thought to seriously increase the risk of developing cervical cancer. This virus is known to infect the genitals, genital tract and area surrounding the anus however not all types of this virus are dangerous and there is now a vaccine to protect against some types of HPV.

There are several factors in relation to sexual history that may increase the chances of developing cervical cancers. These factors may include age, number of partners and exposure. If a woman becomes sexual active at a very young age or has numerous sexual partners it may increase this risk. It may also increase this risk if a woman has sexual encounter with men who had contact with other women that had cervical cancer.

In addition to these factors there are other conditions which may contribute to cervical cancer causes including poverty, eating habits, history of abnormal pap exams and smoking.

When poverty is an issue women may not have the necessary access to receive regular gynecological exams such as pap smears. For this reason when abnormal cells form it goes unnoticed if no symptoms are present.

If a woman does not consume proper amounts of fruit and vegetables it may increase the risk of developing cervical cancer. Smoking may also increase this risk. How much smoking may increase the risk of cervical cancer depends on how long she has been smoking and how much she smokes on a regular basis.

Because most cases of cervical cancer are detected by abnormal pap exams not having these exams can significantly increase the risk of cervical cancer. This is because in many cases these abnormalities are not noticed without the aid of pap exams to detect them.

Women with low immune systems are also at an increased risk of developing cervical cancer. This is sometimes found in women who have tested HIV positive or have aids and in some cases in women who take medications to lower the immune system such as those that have had some sort of organ transplant.

In some cases exposure to some chemicals such as those found on farms or in manufacturing plants may also increase the risk of developing cervical cancer.

Although specific cervical cancer causes are not known it is helpful to know the factors that may increase the risk of developing this type of cancer. If you are in any of the increased risk groups you should above all have regular gynecological exams to detect this cancer as early as possible. The earlier cervical cancer is diagnosed and treated the better off you will be.

Stage 0

In this stage of cervical cancer, cells are only on the surface of the cervix and have not infected deeper tissues. This is the earliest stage of cervical cancer and is often commonly referred to as carcinoma in situ.

Stage I

This stage is divided into two sub levels which are also divided into additional sub levels. Each sub level indicates new developments in relation to the cervical cancer in question. In this stage the cancer cells have infected the cervix but have not spread past the cervix to other areas.

• Stage IA

In the earliest cases of stage IA cervical cancer can only be seen with the use of a microscope. In the early parts of this stage the affected area is usually a depth of less than 1/8 of an inch and a width of less than ¼ of an inch however by the end of this stage the depth may grow up to 1/5 of an inch in depth.

• Stage IB

In this stage cervical cancer has grown enough to be seen without the aid of a microscope and depth may now be in excess or 1/5 of an inch. By the end of this stage the cancer may grow to be as much as 1 ¾ of an inch or larger however in the early parts of this stage it is generally smaller.

Stage II

In the third of the cervical cancer stages cancer may have spread to nearby areas but still has not progressed beyond the pelvic area. In the early parts of this stage cancer may have spread to the upper portion of the vagina however the lower portion is still unaffected. By the end of this stage cancer may spread to the tissues close to the cervix known as the parametrial tissue.

Stage III

In the beginning of stage III cancer has most likely spread to include the lower part of the vagina and as by the end of this stage may also reach the pelvic wall and block urine flow to the bladder.

Stage IV

In the last of the cervical cancer stages cancer has started to spread beyond the pelvic region to include other areas of the body. This is cervical cancer at its most advanced stage and in most cases is considered incurable. Some of the areas of the body that cancer may have spread to by the end of this stage include the lungs, kidneys and other distant parts of the body.

In order to prevent cervical cancer from reaching this point it is important to maintain regular gynecological exams that screen for abnormalities in the cervical cells and report any usual symptoms to your doctor right away.

Not all cell abnormalities or changes will lead to cervical cancer however if these abnormal cells also known as dysplasia are left untreated for extended periods of times they can turn cancerous. After turning cancerous they can spread beyond the cervix into other areas of the body making treatment much more difficult. In some cases cells affected by dysplasia may turn back to normal cells without any form of treatment however it is best to let a doctor determine the chances of this happening.

In order to detect abnormal cell growth and formation it is recommended that girls begin receiving regular screening by a qualified health care professional around the age of 13-15 years. This screening is commonly called a pap smear and this is how most cases of cervical cancer are detected. This test determines if the cells present are normal or show signs of abnormality. When these abnormal cells are caught in the very early stages treatment is usually quite simple and the progression to cervical cancer can be prevented.

Although signs of cervical cancer are not always present early on they may be in some cases as well as in more advanced stages of cervical cancer. For this reason it is important to know what signs to be aware of in association with cervical cancer. Some of the symptoms you may notice are loss of appetite, unexplained weight loss, vaginal bleeding after sex or douching, unusual bleeding between periods or after menopause, bloody or smelly discharge, fatigue, pain during or after sex and pelvic or leg pain. Although these symptoms may not be indicative of cervical cancer in all cases they are still signs that there is a problem and should be dealt with. Any unusual occurrences within your body should be brought to the attention of your health care provider for prompt diagnosis and discussion of treatment options.

If you have experienced any of the signs of cervical cancer or any other symptoms that you feel are unusual or not explained by some other illness or condition it is important that you seek the advice of your family’s health care professional in order to determine the necessity of further action. Further testing may be necessary to determine the presence of cervical cancer. If cervical cancer is found and diagnosed it will then become necessary to determine how advanced it has become. Once this has been done your doctor will discuss treatment options with you. Treatment options will vary from one person to another as not everyone will respond to certain treatments in the same way. In order to determine which treatment will be most effective in your specific case several factors will be considered such as age, general health and stage of cancer. Some treatments may be less effective in advanced stages of cervical cancer.

One very important thing is to know the symptoms of cervical cancer. This will be very beneficial in detection of the disease. In some cases however there are no symptoms present with the early development of cervical cancer. In these cases it becomes even more important for a woman to have regular exams known as pap smears. This test screens for possible abnormalities in the cervical cells among other things. It is recommended that Pap smear exams be performed on all females beginning around the age of 13-15 years. Most cases of cervical cancer are discovered during Pap smear exams. When abnormalities of cervical cells are detected during a pap smear other testing may be necessary to determine the cause of these abnormalities. Not all abnormal results will be caused by cervical cancer. There are other less serious conditions that may cause these abnormalities as well.

Some symptoms of cervical cancer may include vaginal bleeding other than that of your regular monthly cycle or painful intercourse. In addition to this other symptoms that may be noticed are unusual foul smelling vaginal discharge, bloody discharge, painful urination due to a possible kidney blockage, bleeding after sexual contact and pain in the pelvis area. Not all of these symptoms are indicative of cervical cancer however they still represent a problem that needs attention. It is important to seek medical consultation at the presence of these or any other out of the ordinary symptoms that you may be experiencing.

Detecting cervical cancer at the earliest possible stage is essential part of treatment. Although there are several methods of treatment available for this type of cancer some of these may be unavailable or ineffective for advanced cases of this disease. In order to determine which treatment will be most effective it is first necessary for the condition to be properly diagnosed. In order to achieve this it is important to see a health care profession at the first notice of symptoms of cervical cancer.

In some cases treatment of cervical cancer may cause infertility or inability to have children however in younger females steps are taken to prevent this whenever and wherever possible. If you are concerned about your ability to have children following treatment of cervical cancer it is very important that you discuss this with your doctor before treatment is started. This is especially true in younger females or those who have not yet had children. In some cases waiting until after treatment has begun is too late.

Women across the globe have been inflicted with cervical cancer, making it the second widespread type of cancer that affects females. Cervical cancer treatments have transformed manifestly over the span of the previous ten years as a consequence of the parameters laid down by NCI or National Cancer Institute a decade back stating that chemoradiotherapy must be deemed as a substitute for radiotherapy.

Chemoradiotherapy merges chemotherapy (therapy employing cancer-combatant drugs) and X-ray therapy, while radiotherapy is merely treatment via X-rays.

The researchers perceived lucid proof that when chemotherapy was added to radiotherapy then it enhanced chances of surviving alongside survival that was free from ailments. These are effectual, reasonably priced therapies that the researchers believe could offer a standard for other possible therapy advancements.

The investigators probed data derived from fifteen studies that involves a totality of almost three thousand five hundred women entrants. They detected that in comparison to the women that had received solely radiotherapy, all those women having received chemoradiotherapy were observed to have a lengthier life span following therapy. 5 years subsequent to having received therapy, sixty-six out of the every one hundred females were observed to survive the ailment after having undergone chemoradiotherapy in comparison to sixty from one hundred women that had been given radiotherapy.

Additionally, being treated with chemoradiotherapy lowered the likelihood of cancer relapsing or recurring or metastasizing to other regions of the body. Decisively, investigations performed by the researchers revealed that the advantages of chemoradiotherapy were not merely limited to the platinum-based medicines suggested by the National Cancer Institute.

On the basis of a small-sized sub-group of the data, there was additionally an implication that carrying on drug treatment following chemoradiotherapy could enhance survival chance even more, though the scientists stated further researches are necessary for corroborating it. However, the investigators indicate that novel studies are required for finding out if further chemotherapy offered would or would not provide better benefits to women having cervical cancer.

HPV or Human Papillomavirus virus are presently widely obtainable for preventing Cervical Cancer. The Quadrivalent vaccine – Gardasil and the bivalent vaccine – Cervarix have received FDA approval for this reason.

Broad-spectrum Information

• The Human Papilloma Virus (high-risk genetic makeup) is an indispensable underlying factor of cervical cancers.
• The HPV vaccine is a preventative vaccine with the duo, namely: bivalent and the quadrivalent vaccine offering safeguard against HPV infection (HPV genotypes 16 and 18) that constitute nearly seventy percent of HPV-linked cervical cancers. The quadrivalent vaccine additionally defends against HPV genotypes 6 and 11 which are accountable for nearly ninety percent of the genital warts.
• The HPV vaccine is not remedial and does not help in treating already present HPV infection or cervical intraepithelial neoplasia (cervical pre-malignant phase).

Cervical Cancer Screening

Women that have been inoculated with the HPV vaccine must continue getting screened for cervical cancer.

Inoculation Target Category

• The bivalent vaccine has received FDA approval for being used on females in the ages of 10-45 years, while the quadrivalent vaccine has garnered FDA approval for usage among females in the age bracket of 9-26 years.
• The vaccine is intended to target females at their most expedient and optimal age that would be between 12 to 16 years for inoculation prior to their foremost sexual encounter.
• Regular HPV vaccination is suggested for females lying in between ten to twelve years of age.
• HPV vaccination could be administered to all females till 26 years of age, in the case of bivalent vaccine till 45 years of age, irrespective of sexual activity, however meagre benefits are gained from it when one is by now sexually active. The resolution depends on the detailed discussion in-between the woman and the health care provider about risks of past HPV exposure and latent advantages gained from the inoculation.

Dose Scheduling

• In case of the quadrivalent vaccine, 3 intramuscular doses spaced at zero, two and six months are suggested (The smallest intervals in-between dosages are a month’s time in-between first and the second dosage and three months in-between second and third dosage).
• In case of the bivalent vaccine, 3 intramuscular doses spaced out at zero, one and six months are suggested.
• Presently there are no facts for backing the usage of boosters for the same.

Counselling prior to Inoculation

• A detailed understanding of the purpose, action and efficacy of the vaccine need to be furnished to the woman or her parent/guardian concerned whenever pertinent, prior to inoculation.
• The elucidation must classically comprise: the function of HPV in cervical carcinogenesis – particularly in the case of HPV genotypes 16 and 18; trial outcomes and prospects; immunological reactions; safety and efficiency; alongside clearing all relevant doubts.

HPV Testing Prior To Inoculation

Getting tested for HPV is not suggested prior to undergoing inoculation.

Inoculation of Women in the sexually active category

• Women that are either sexually active or with a past of irregular cervical cytology could get vaccinated, however the advantages could be restricted to the safeguard against HPV genotype infection with which they haven’t been infected.
• Women that have been infected with HPV –type (serologically affirmative) and have received clearance for the cervical infection (DNA negative) seems to have analogous defensive effects as those that are naive to the analogous vaccine HPV-type. Additional scientific proof is expected on this matter.

Unusual Situations (Those women with Past CIN or Cervical Intraepithelial Neoplasia)

• The vaccine could be administered to women that had previously developed CIN, however the advantages gained could be restricted to the safeguard against infection of HPV genotypes (and associated CIN) with which they haven’t been infected.
• Emphasis on continued cervical screening and equivalent management.

Pregnant and Lactating Women

• The employment of the vaccine during pregnancy is not considered ideal, though no teratogenic effect occurring due to the vaccine has been cited.
• There are no facts that reveal that the HPV vaccine has detrimental outcome on fertility, pregnancy or fetal outcome.
• However, women that plan to have a child are recommended to postpone the vaccination till after childbirth.
• Aborting pregnancy is not indicated in women that became accidentally pregnant during the course of inoculation.
• Lactating women could get the HPV vaccine and yet carry on breastfeeding their child as it is a vaccine with no subsisting viral DNA.

Immunosuppression

• Immunosuppression is not contraindicated to inoculation. But, the immune reaction to the HPV vaccine might be less proficient among such women as compared to individuals in good health.

Contraindications and Precautionary Measures

• In case of the HPV vaccine there are contraindications for individuals having a past of hypersensitivity towards a particular vaccine constituent.
• Vaccine needs to be offered in a lying down stance and the individual must be kept under observation for nearly fifteen minutes as it could cause probable giddiness or fainting spells.
• When the vaccine is being administered alongside any other vaccine, it needs to be given on a separate spot using a different syringe.